Comparing modular and personal service delivery in specialised outpatient care: A survey of haematology and oncology patient preferences

Comparing modular and personal service delivery in specialised outpatient care: A survey of haematology and oncology patient preferences
Health Services Management Research Volume: 32 issue: 4, page(s): 209-217, 12 August 2019 https://doi.org/10.1177/0951484819868681

• This study compares preferences of oncology patients treated by named nurses in a traditional specialty-focused day hospital and haematology patients treated without named nurses in a modularised day hospital. 
• The findings suggests that patients can be satisfied with outpatient care with or without named nurses. However, as several factors affect patient satisfaction and experience, more in-depth research is needed to understand how modularisation and patient preferences may be linked.

Abstract

Paediatric home monitoring in CF

Is paediatric home monitoring in CF feasible? There’s an app for that!
Digital Health London 27 September 2018

• CLIMB-CF is a study, funded by the CF Trust and run from Imperial College London, exploring whether it is possible to monitor children and young people with Cystic Fibrosis  at home using an app and some Bluetooth equipment.(https://www.cysticfibrosis.org.uk/the-work-we-do/clinical-care/smartcarecf/climb-cf). 
• The app is currently on trial in the UK and Canada.

Safety and feasibility of home-based chemotherapy.

Safety and feasibility of home-based chemotherapy.
Dan Med J. 2018 May;65(5). pii: A5482.

• This research study found that home-based chemotherapy is feasible and safe for patients who had undergone radical surgery for colon cancer, and that it might be a valuable alternative to treatment at an outpatient clinic.
• Location of study: Denmark

Optimising design of out of hospital services for Denosumab

Optimising design of out of hospital services for Denosumab
Cancer Vanguard 23 October 2017

• UCLH Cancer Collaborative has partnered with Amgen to develop a simulation modelling tool that allows multiple delivery pathways of denosumab (whether in hospital, in primary care, in the community or at home) to be to be tested for financial and patient experience impact. 
• An options appraisal document and user guide will accompany the model in a toolkit available to all NHS Trusts and CCGs. 
• The project toolkit is accessible to NHS staff with an NHS email address. 
• Register here to access the materials.